These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 20683028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, Ide S, Takahashi H, Kobashi G, Kyushu Sapporo SLE (KYSS) Study Group.
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [Abstract] [Full Text] [Related]

  • 7. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S.
    Int J Cancer; 2004 Jul 01; 110(4):598-604. PubMed ID: 15122594
    [Abstract] [Full Text] [Related]

  • 8. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K.
    Int J Cancer; 2005 Apr 20; 114(4):579-84. PubMed ID: 15609332
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J, Kropp S, Jäger B, Bartsch H, Risch A.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 20; 11(8):698-704. PubMed ID: 12163321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S, Medeiros R, Vasconcelos A, Pinto D, Lopes C.
    J Cancer Res Clin Oncol; 2002 Dec 20; 128(12):678-82. PubMed ID: 12474054
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population.
    Liu HE, Hsiao PY, Lee CC, Lee JA, Chen HY.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar 20; 17(3):661-5. PubMed ID: 18349284
    [Abstract] [Full Text] [Related]

  • 16. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
    Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T.
    Int J Urol; 2003 Mar 20; 10(3):167-73. PubMed ID: 12622714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM.
    Int J Hyg Environ Health; 2003 Jun 20; 206(3):149-71. PubMed ID: 12872524
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer.
    Sørensen M, Autrup H, Tjønneland A, Overvad K, Raaschou-Nielsen O.
    Cancer Lett; 2005 Apr 28; 221(2):185-90. PubMed ID: 15808404
    [Abstract] [Full Text] [Related]

  • 20. N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer.
    Rabstein S, Brüning T, Harth V, Fischer HP, Haas S, Weiss T, Spickenheuer A, Pierl C, Justenhoven C, Illig T, Vollmert C, Baisch C, Ko YD, Hamann U, Brauch H, Pesch B, GENICA Network.
    Eur J Cancer Prev; 2010 Mar 28; 19(2):100-9. PubMed ID: 19996973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.